EPCAM and kidney cancer: However, the application of EpCAM as a biomarker for tumor cell isolation from blood, bone marrow, lymph nodes, and biopsy samples is not suitable for colon cancer, kidney cancer, liver cancer, and thyroid cancer, in which EpCAM exhibits repressed or comparable expression levels compared to normal tissues (Figure S5B,C).